# TeclisAMY (NCT06649695)

> A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06649695
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: European Myeloma Network B.V.
- Conditions: AL Amyloidosis
- Interventions: Teclistamab
- Enrollment: 30
- Primary outcome: Hematologic Complete Response (CR) rate

## Indexed commentary on TeclisAMY so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=teclisamy-nct06649695